Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome

Mycobacteria harbor two main degradative proteolytic machineries, the caseinolytic protease ClpP1P2 and a proteasome. We recently showed that Bortezomib inhibits ClpP1P2 and exhibits whole cell activity against Mycobacterium tuberculosis. Bortezomib, a dipeptide with a boronic acid warhead, is a hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Wilfried, Santhanakrishnan, Sridhar, Dymock, Brian W., Dick, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406460/
https://www.ncbi.nlm.nih.gov/pubmed/28496439
http://dx.doi.org/10.3389/fmicb.2017.00746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406460/
https://www.ncbi.nlm.nih.gov/pubmed/28496439
http://dx.doi.org/10.3389/fmicb.2017.00746

Ejemplares similares